Background: The waist-to-height ratio (WHtR) may be a better adiposity measure than the body mass index (BMI). We evaluated the prognostic performance of WHtR in patients with acute ischemic stroke (AIS). Methods: First, we compared WHtR and BMI as adiposity measures in 712 healthy adults by tetrapolar bioimpedance analysis. Thereafter, baseline WHtR was analyzed as predictor of 12-month all-cause mortality in 821 Mexican mestizo adults with first-ever AIS by a Cox proportional hazards model adjusted for baseline predictors. Results: In healthy individuals, WHtR correlated higher than BMI with total fat mass and showed a higher accuracy in identifying a high percentage of body fat (p < 0.01). In AIS patients a U-shaped relationship was observed between baseline WHtR and mortality (fatality rate 29.1%). On multivariate analysis, baseline WHtR ≤0.300 or >0.800 independently predicted 12-month all-cause mortality (hazard ratio 1.91, 95% confidence interval 1.04-3.51). BMI was not associated with mortality, tested either as continuous, binomial or stratified variable. Conclusion: WHtR is a modifiable risk factor that accurately demonstrates body fat excess. Extreme WHtR values were associated with increased 12-month all-cause mortality in Mexican mestizo patients with AIS. No survival advantage was found with high WHtR as the pragmatic indicator of obesity in this population.

1.
Oki I, Nakamura Y, Okamura T, Okayama A, Hayakawa T, Kita Y, Ueshima H: Nippon Data80 Research Group: Body mass index and risk of stroke mortality among a random sample of Japanese adults: 19-year follow-up of NIPPON DATA80. Cerebrovasc Dis 2006;22:409-415.
2.
Bodenant M, Kuulasmaa K, Wagner A, Kee F, Palmieri L, Ferrario MM, Montaye M, Amouyel P, Dallongeville J: MORGAM Project: measures of abdominal adiposity and the risk of stroke: the MOnica Risk, Genetics, Archiving and Monograph (MORGAM) study. Stroke 2011;42:2872-2877.
3.
Gruberg L, Weissman NJ, Waksman R, Fuchs S, Deible R, Pinnow EE, Ahmed LM, Kent KM, Pichard AD, Suddath WO, Satler LF, Lindsay J Jr: The impact of obesity on the short-term and long-term outcomes after percutaneous coronary intervention: the obesity paradox? J Am Coll Cardiol 2002;39:578-584.
4.
Curtis JP, Selter JG, Wang Y, Rathore SS, Jovin IS, Jadbabaie F, Kosiborod M, Portnay EL, Sokol SI, Bader F, Krumholz HM: The obesity paradox: body mass index and outcomes in patients with heart failure. Arch Intern Med 2005;165:55-61.
5.
Kim BJ, Lee SH, Ryu WS, Kim CK, Lee J, Yoon BW: Paradoxical longevity in obese patients with intracerebral hemorrhage. Neurology 2011;76:567-573.
6.
Vemmos K, Ntaios G, Spengos K, Savvari P, Vemmou A, Pappa T, Manios E, Georgiopoulos G, Alevizaki M: Association between obesity and mortality after acute first-ever stroke: the obesity-stroke paradox. Stroke 2011;42:30-36.
7.
Lee K, Song YM, Sung J: Which obesity indicators are better predictors of metabolic risk? Healthy twin study. Obesity (Silver Spring) 2008;16:834-840.
8.
Chiquete E, Cantú-Brito C, Villarreal-Careaga J, Murillo-Bonilla LM, Rangel-Guerra R, León-Jiménez C, Ochoa-Guzmán A, Ramos-Moreno A, Arauz A, Barinagarrementeria F, Panduro A, Ruiz-Sandoval JL: Obesity paradox and functional recovery in first-ever acute ischemic stroke survivors: the PREMIER study (in Spanish). Rev Neurol 2010;51:705-713.
9.
Ashwell M, Gunn P, Gibson S: Waist-to-height ratio is a better screening tool than waist circumference and BMI for adult cardiometabolic risk factors: systematic review and meta-analysis. Obes Rev 2012;13:275-286.
10.
Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: The first Mexican multicenter register on ischaemic stroke (the PREMIER study): demographics, risk factors and outcome. Int J Stroke 2011;6:93-94.
11.
Cantú-Brito C, Ruiz-Sandoval JL, Murillo-Bonilla LM, Chiquete E, León-Jiménez C, Arauz A, Villarreal-Careaga J, Barinagarrementeria F, Ramos-Moreno A; PREMIER Investigators: Acute care and one-year outcome of Mexican patients with first-ever acute ischemic stroke: the PREMIER study. Rev Neurol 2010;51:641-649.
12.
Chiquete E, Ruiz-Sandoval JL, Murillo-Bonilla LM, Arauz-Góngora A, Ochoa-Guzmán A, Villarreal-Careaga J, León-Jiménez C, Barinagarrementeria F, Ramos-Moreno A, Cantú-Brito C: Serum uric acid and outcome after acute ischemic stroke: PREMIER study. Cerebrovasc Dis 2013;35:168-174.
13.
Koton S, Molshatzki N, Bornstein NM, Tanne D: Low cholesterol, statins and outcomes in patients with first-ever acute ischemic stroke. Cerebrovasc Dis 2012;34:213-220.
14.
Ryu WS, Lee SH, Kim CK, Kim BJ, Yoon BW: Body mass index, initial neurological severity and long-term mortality in ischemic stroke. Cerebrovasc Dis 2011;32:170-176.
15.
Calle EE, Thun MJ, Petrelli JM, Rodriguez C, Heath CW Jr: Body mass index and mortality in a prospective cohort of US adults. N Engl J Med 1999;341:1097-1105.
16.
Jee SH, Sull JW, Park J, Lee SY, Ohrr H, Guallar E, Samet JM: Body mass index and mortality in Korean men and women. N Engl J Med 2006;355:779-787.
17.
Pischon T, Boeing H, Hoffmann K, Bergmann M, Schulze MB, Overvad K: General and abdominal adiposity and risk of death in Europe. N Engl J Med 2008;359:2105-2120. Erratum in: N Engl J Med 2010;362:2433.
18.
Chrysant SG, Chrysant GS: New insights into the true nature of the obesity paradox and the lower cardiovascular risk. J Am Soc Hypertens 2013;7:85-94.
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.